Journal of Cataract & Refractive Surgery
Volume 31, Issue 7 , Pages 1306-1313 , July 2005

Systematic evaluation of wavefront-guided outcomes

,Accepted 26 January 2005.

References 

  1. Thibos LN. Wavefront data reporting and terminology. J Refract Surg. 2001;17:S578–S583
  2. Waring GO. Standard graphs for reporting refractive surgery. J Refract Surg. 2000;16:459–466
  3. Koch D. Measuring patient outcomes after refractive surgery. J Cataract Refract Surg. 2001;27:645–646
  4. Chalita MR, Xu M, Krueger RR. Correlation of aberrations with visual symptoms using wavefront analysis in eyes after laser in situ keratomileusis. J Refract Surg. 2003;19:S682–S686
  5. Holladay JT, Dudeja DR, Chang J. Functional vision and corneal changes after laser in situ keratomileusis determined by contrast sensitivity, glare testing, and corneal topography. J Cataract Refract Surg. 1999;25:663–669
  6. Thibos LN, Applegate RA, Schwiegerling JT, Webb R, VSIA Standards Taskforce Members . Standards for reporting the optical aberrations of eyes. J Refract Surg. 2002;18:S652–S660
  7. Atchison DA. Recent advances in representation of monochromatic aberrations of human eyes. Clin Exp Optom. 2004;87:138–148
  8. Holladay JT, Moran JM, Kezirian GM. Analysis of aggregate surgically induced refractive change, prediction error, and intraocular astigmatism. J Cataract Refract Surg. 2001;27:61–79
  9. Alpins N. Analysis of aggregate surgically induced refractive change, prediction error, and intraocular astigmatism. J Refract Surg. 2001;17:705–707
  10. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–391

 Presented at the 5th International Congress of Wavefront Sensing and Optimized Refractive Corrections, Whistler, British Columbia, Canada, February 2004.No author has a financial or proprietary interest in any material or method mentioned.The following individuals contributed in the preparation of this manuscript: David A. Atchison, PhD, FAAO (School of Optometry, Queensland University of Technology, Queensland, Australia); Michael Mrochen, PhD (Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology, Zurich, Switzerland).The comments presented here represent the professional opinions of the authors and do not constitute an official document, guidance or policy of the U.S. Government, the Department of Health and Human Services, or the Food and Drug Administration, nor should any official endorsement be inferred.

PII: S0886-3350(05)00288-9

doi: 10.1016/j.jcrs.2005.01.028

Journal of Cataract & Refractive Surgery
Volume 31, Issue 7 , Pages 1306-1313 , July 2005

Article Tools

* Image Usage & Resolution